really excited to see how PTX-100 plays out in this initial data. the multiple potential uses for it is really exciting.
pembrolizumab (Merck) was initially approved for melanoma only, with subsequent research its been approved now for lung cancer (incl. 1st line treatment), colorectal ca, head/neck, bladder/kidney, lymphoma and etc...nearly $US15 billion of sales last year....
touch wood the ability to find numerous indications where It can be studied makes it a true company maker.
dont even get me started on the omnicar lol.
- Forums
- ASX - By Stock
- PTX
- sp should be 5x imho
sp should be 5x imho, page-550
-
- There are more pages in this discussion • 488 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $32.61M |
Open | High | Low | Value | Volume |
4.1¢ | 4.1¢ | 4.1¢ | $422 | 10.30K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 767493 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 202902 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 767493 | 0.040 |
6 | 589000 | 0.039 |
3 | 273000 | 0.038 |
4 | 289000 | 0.037 |
2 | 375000 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 202902 | 3 |
0.042 | 25000 | 1 |
0.043 | 68837 | 2 |
0.044 | 200000 | 1 |
0.045 | 831675 | 6 |
Last trade - 10.24am 13/08/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online